CCR5 is a receptor for Staphylococcus aureus leukotoxin ED
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Pore-forming toxins are critical virulence factors for many bacterial pathogens and are central to Staphylococcus aureus-mediated killing of host cells. S. aureus encodes pore-forming bi-component leukotoxins that are toxic towards neutrophils, but also specifically target other immune cells. Despite decades since the first description of staphylococcal leukocidal activity, the host factors responsible for the selectivity of leukotoxins towards different immune cells remain unknown. Here we identify the human immunodeficiency virus (HIV) co-receptor CCR5 as a cellular determinant required for cytotoxic targeting of subsets of myeloid cells and T lymphocytes by the S. aureus leukotoxin ED (LukED). We further demonstrate that LukED-dependent cell killing is blocked by CCR5 receptor antagonists, including the HIV drug maraviroc. Remarkably, CCR5-deficient mice are largely resistant to lethal S. aureus infection, highlighting the importance of CCR5 targeting in S. aureus pathogenesis. Thus, depletion of CCR5(+) leukocytes by LukED suggests a new immune evasion mechanism of S. aureus that can be therapeutically targeted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The respective immune cell receptor counterparts of these leukocidins have been identified (Alonzo et al., 2013; DuMont et al., 2013; Reyes-Robles et al., 2013; Spaan et al., 2013a; Spaan et al., 2014).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Alonzo et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
Self-citationLiu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Self-citationSamson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Immune evasion by staphylococci
Foster, T. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1289 · Cited by 1,222
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., & Sallusto, F. (2012) · Nature · doi:10.1038/nature10957 · Cited by 919
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
Cho, J. S., Pietras, E. M., Garcia, N. C., Ramos, R. I., Farzam, D. M., Monroe, H. R., Magorien, J. E., Blauvelt, A., Kolls, J. K., Cheung, A. L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40891 · Cited by 658
Lin, L., Ibrahim, A. S., Xu, X., Farber, J. M., Avanesian, V., Baquir, B., Fu, Y., French, S. W., Edwards, J. E., & Spellberg, B. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000703 · Cited by 465
Research works printed but not linked: 1
- Van de Velde H Etude sur le mécanisme de la virulence du staphylocoque pyogène La Cellule 1894 403 460
Cited by
Items 101–200 of 298
Shambat, S. M., Chen, P., Hoang, A. T. N., Bergsten, H., Vandenesch, F., Siemens, N., Lina, G., Monk, I. R., Foster, T. J., Arakere, G., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.021923 · Cited by 62
“The bi-component cytotoxins leukocidins LukAB, LukED and PVL target specific complement and chemokine receptors (Alonzo et al., 2013; Alonzo and Torres, 2013; DuMont et al., 2013), and the strict cell and host specificity of PVL could be linked to interspecies variation in C5aR (Spaan et al., 2013).”
Escajadillo, T., & Nizet, V. (2018) · Toxins · doi:10.3390/toxins10120542 · Cited by 56
Sanchez, M., Kolar, S. L., Müller, S., Reyes, C. N., Wolf, A. J., Ogawa, C., Singhania, R., Carvalho, D. D. D., Arditi, M., Underhill, D. M., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.08.008 · Cited by 57
Han, E., Li, X., Zhang, Y., Zhang, M., Cai, J., & Zhang, X. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113982 · Cited by 56
Mechanisms of host adaptation by bacterial pathogens
Barber, M. F., & Fitzgerald, J. R. (2024) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuae019 · Cited by 72
“In recent years, it has been shown that man y sta phylococcal por e-forming toxins target host cells through recognition of specific host cell surface receptors (Inoshima et al. 2011 , Alonzo et al. 2013 , DuMont et al. 2013 , Spaan et al. 2015 , Lubkin et al. 2019 ).”
BackgroundHost factors that contribute to recurrent staphylococcal skin infection
Montgomery, C. P., David, M. Z., & Daum, R. S. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000156 · Cited by 57
Rouha, H., Weber, S., Janesch, P., Maierhofer, B., Gross, K., Doležílková, I., Mirkina, I. I., Visram, Z., Malafa, S., Stulik, L., et al. (2017) · Virulence · doi:10.1080/21505594.2017.1391447 · Cited by 48
Lung, T. W. F., Chan, L. C., Prince, A. S., Yeaman, M. R., Archer, N. K., Aman, M. J., & Proctor, R. A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1060810 · Cited by 50
“Moreover, MAIT cells are susceptible to leukocidin ED-mediated lysis, which was mediated through CCR5 binding (Boulouis et al., 2022).”
BackgroundInfluentialKaus, K., Lary, J. W., Cole, J. L., & Olson, R. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.05.021 · Cited by 55
“Protein receptors have been identified for several VVH-homologous staphylococcal toxins including ADAM10 as a receptor for α-hemolysin [7], CCR5 as a receptor for leukotoxin ED [8], and C5a receptors as targets of Panton-Valentine Leukocidin [9].”
Studying Staphylococcal Leukocidins: A Challenging Endeavor
Tromp, A. T., & van Strijp, J. A. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00611 · Cited by 51
Pozzi, C., Lofano, G., Mancini, F., Soldaini, E., Speziale, P., Gregorio, E. D., Rappuoli, R., Bertholet, S., Grandi, G., & Bagnoli, F. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv024 · Cited by 46
“Recently, the C-C chemokine receptor 5 has been identified as a cellular receptor used by LukED to kill lymphocytes, macrophages and dendritic cells (Alonzo et al. 2013).”
BackgroundAnderson, M. C., Ohr, R. J., Aly, K. A., Nocadello, S., Kim, H. K., Schneewind, C. E., Schneewind, O., & Missiakas, D. M. (2016) · Journal of Bacteriology · doi:10.1128/jb.00527-16 · Cited by 46
Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia
Vlaeminck, J., Raafat, D., Surmann, K., Timbermont, L., Normann, N., Sellman, B. R., van Wamel, W. J. B., & Malhotra‐Kumar, S. (2020) · Toxins · doi:10.3390/toxins12110721 · Cited by 46
“HIV and LukED share the CCR5 receptor as a cellular target, but bind to different sequence determinants [108,186].”
BackgroundInfluentialStaphylococcal Bicomponent Pore-Forming Toxins: Targets for Prophylaxis and Immunotherapy
Aman, M. J., & Adhikari, R. P. (2014) · Toxins · doi:10.3390/toxins6030950 · Cited by 55
“The HIV co-receptor CCR5 was shown to mediate binding and cytolysin formation by LukED [34].”
BackgroundInfluentialCounter inhibition between leukotoxins attenuates Staphylococcus aureus virulence
Yoong, P., & Torres, V. J. (2015) · Nature Communications · doi:10.1038/ncomms9125 · Cited by 41
“LukED does not exhibit species specificity and similarly targets human and murine cells expressing the G-protein coupled chemokine receptors CCR5, CXCR1 and CXCR2 (refs 9,10).”
InfluentialSelf-citationStaphylococcus aureus Infection and Persistence in Chronic Rhinosinusitis: Focus on Leukocidin ED
Poddighe, D., & Vangelista, L. (2020) · Toxins · doi:10.3390/toxins12110678 · Cited by 41
“The most immediate candidate to block LukED targeting of CCR5+ cells is maraviroc, a small chemical CCR5 antagonist that is FDA-approved as an HIV-1 entry inhibitor that has already been reported to efficiently inhibit LukED [39].”
BackgroundInfluentialMelehani, J. H., & Duncan, J. A. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_13 · Cited by 43
Narayana, S. G., de Jong, E., Schenkel, F. S., Fonseca, P. A. D. S., Chud, T. C. S., Powell, D., Wachoski-Dark, G. L., Ronksley, P. E., Miglior, F., Orsel, K., et al. (2022) · Journal of Dairy Science · doi:10.3168/jds.2022-21923 · Cited by 43
Vasquez, M. T., Lubkin, A., Robles, T. R., Day, C. J., Lacey, K. A., Jennings, M. P., & Torres, V. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015757 · Cited by 44
Self-citationStaphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice
Lubkin, A., Lee, W. L., Alonzo, F., Wang, C., Aligo, J. A., Keller, M., Girgis, N. M., Robles, T. R., Chan, R., O’Malley, A., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.015 · Cited by 41
Self-citationEpidemiological and Clinical Evidence for the Role of Toxins in S. aureus Human Disease
Bennett, M. R., & Thomsen, I. P. (2020) · Toxins · doi:10.3390/toxins12060408 · Cited by 40
Staphylococcus aureus Pore-Forming Toxins
Robles, T. R., & Torres, V. J. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_16 · Cited by 41
Self-citationBacterial virulence plays a crucial role in MRSA sepsis
Cheung, G. Y. C., Bae, J. S., Liu, R., Hunt, R. L., Zheng, Y., & Otto, M. J. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009369 · Cited by 42
T Cell Immunity and the Quest for Protective Vaccines against Staphylococcus aureus Infection
Armentrout, E. I., Liu, G. E., & Martins, G. A. (2020) · Microorganisms · doi:10.3390/microorganisms8121936 · Cited by 38
“Additional staphylococcal strategies consist of the expression of an MHC class II analog protein (Map), which binds directly to TCR to attenuate T cell responses [74], and the expression of the LukED toxin that lyses T cells following ligation to the CCR5 receptor [75].”
Backgroundα‐hemolysin of Staphylococcus aureus impairs thrombus formation
Jahn, K., Handtke, S., Palankar, R., Kohler, T. P., Wesche, J., Wolff, M., Bayer, J., Wolz, C., Greinacher, A., & Hammerschmidt, S. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15703 · Cited by 36
Staphylococcus aureus: setting its sights on the human innate immune system
Buchan, K. D., Foster, S. J., & Renshaw, S. A. (2019) · Microbiology · doi:10.1099/mic.0.000759 · Cited by 43
Laabei, M., Jamieson, W. D., Massey, R. C., & Jenkins, A. T. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087270 · Cited by 37
“In similar fashion to the alpha-toxin, these leukocidins require specific receptor(s) for lysing biological membranes [32,33,34,35] but may still lyse artificial membranes [36].”
BackgroundAdhikari, R. P., Kort, T., Shulenin, S., Kanipakala, T., Ganjbaksh, N., Roghmann, M., Holtsberg, F. W., & Aman, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137874 · Cited by 38
Martin, D. R., Witten, J. C., Tan, C. D., Rodríguez, E. R., Blackstone, E. H., Pettersson, G., Seifert, D. E., Willard, B. B., & Apte, S. (2020) · JCI Insight · doi:10.1172/jci.insight.135317 · Cited by 36
Sheahan, K.-L., & Isberg, R. R. (2015) · mBio · doi:10.1128/mbio.02023-14 · Cited by 35
“CCR5 was recently identified to be a receptor for the LukED pore-forming toxin from Staphylococcus aureus, whose primary target is neutrophils (38, 39).”
BackgroundDynamic interactions between dermal macrophages and Staphylococcus aureus
Feuerstein, R., Kolter, J., & Henneke, P. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0316-097rr · Cited by 34
“resolution of otherwise detrimental infections [17].”
BackgroundTargeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia
Tam, K., Lacey, K. A., Devlin, J. C., Coffre, M., Sommerfield, A. G., Chan, R., O’Malley, A., Koralov, S. B., Loke, P., & Torres, V. J. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190541 · Cited by 33
Self-citationHost–Bacterium Interaction Mechanisms in Staphylococcus aureus Endocarditis: A Systematic Review
Nappi, F., & Singh, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311068 · Cited by 34
“(2013) Nature [65] Animal Single center (USA) CCR5-deficient mice To study activity of S.”
BackgroundRole of Pore-Forming Toxins in Neonatal Sepsis
Sonnen, A. F. ‐., & Henneke, P. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/608456 · Cited by 35
“aureus-specific CCR5-positive Th1/Th17 cells [112], thus greatly contributing to the spread of S.”
BackgroundImpact of smoking on dendritic cell phenotypes in the airway lumen of patients with COPD
Stoll, P., Heinz, A.-S., Bratke, K., Bier, A., Garbe, K., Kuepper, M., Virchow, J. C., Jr., & Lommatzsch, M. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-48 · Cited by 31
“In some cases, a CCR5-mediated entry of these microbial antigens can have detrimental effects on immune cells and suppress antimicrobial immune responses [29,30].”
BackgroundThe chemokine receptor CCR5: multi-faceted hook for HIV-1
Faivre, N., Vérollet, C., & Dumas, F. (2024) · Retrovirology · doi:10.1186/s12977-024-00634-1 · Cited by 34
“This has for instance been described for pathogenic bacteria Staphylococcus aureus (whose toxins interacts with CCR5 chemokine receptor) [31], for Human Respiratory Syncytial Virus (that binds to CX3CR1 chemokine receptor) [32–34] and HIV (that uses CCR5 and/or CXCR4 chemokine receptors to attach…”
BackgroundDarwish, A. S., Bayaumy, F. E. A., & Ismail, H. M. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.09.007 · Cited by 30
Liu, J., Kozhaya, L., Torres, V. J., Unutmaz, D., & Lu, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012697 · Cited by 33
Self-citationEvasion of Immunological Memory by S. aureus Infection: Implications for Vaccine Design
Teymournejad, O., & Montgomery, C. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633672 · Cited by 30
“Antibody levels against LukS, LukE, HlgA, HlgC, LukF, LukD, HlgB, Hla, and Hla were high in children with S. aureus infection, compared with healthy controls (46).”
BackgroundInfluentialZwack, E. E., Chen, Z., Devlin, J. C., Li, Z., Zheng, X., Weinstock, A., Lacey, K. A., Fisher, E. A. A., Fenyö, D., Ruggles, K. V., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123017119 · Cited by 31
Self-citationNeutrophil evasion strategies by Streptococcus pneumoniae and Staphylococcus aureus
Lewis, M. L., & Surewaard, B. G. J. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2737-2 · Cited by 31
Thomas, A., Chothe, S. K., Byukusenge, M., Mathews, T., Pierre, T., Kariyawasam, S., Luley, E., Kuchipudi, S. V., & Jayarao, B. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248528 · Cited by 31
“CXCR2 is the bovine receptor for lukED, but this leucocidin also interacts with CCR5 [78, 79].”
BackgroundIdentification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus
Chan, R., Buckley, P. T., O’Malley, A., Sause, W. E., Alonzo, F., Lubkin, A., Boguslawski, K. M., Payne, A., Fernandez, J., Strohl, W. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0882 · Cited by 31
Self-citationBuckley, P. T., Chan, R., Fernandez, J., Luo, J., Lacey, K. A., Dumont, A., O’Malley, A., Brezski, R. J., Zheng, S., Malia, T., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.04.004 · Cited by 28
Self-citationThomsen, I. P., & Liu, G. Y. (2018) · JCI Insight · doi:10.1172/jci.insight.98216 · Cited by 30
“aureus also secretes a major histocompatibility complex–like molecule that is thought to drive T cell differentiation toward a Th2 phenotype (97) and toxins that induce T cell cytolysis or apoptosis (59, 98), both of which could adversely affect host protective memory.”
BackgroundKim, M.-K. (2019) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-019-0059-9 · Cited by 28
Inhibition of Pore-Forming Proteins
Omersa, N., Podobnik, M., & Anderluh, G. (2019) · Toxins · doi:10.3390/toxins11090545 · Cited by 31
Dendritic cell functions: Learning from microbial evasion strategies
Rescigno, M. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.012 · Cited by 27
Staphylococcal superantigen-like protein 13 activates neutrophils via formyl peptide receptor 2
Zhao, Y., van Kessel, K. P. M., de Haas, C. J. C., Rogers, M. R. C., van Strijp, J. A. G., & Haas, P. (2018) · Cellular Microbiology · doi:10.1111/cmi.12941 · Cited by 28
Ellwanger, J. H., Kaminski, V. D. L., Rodrigues, A. G., Kulmann‐Leal, B., & Chies, J. A. B. (2020) · International Journal of Immunogenetics · doi:10.1111/iji.12485 · Cited by 30
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies
Hsieh, R. C., Liu, R., Burgin, D. J., & Otto, M. J. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2242585 · Cited by 26
Macrophage-to-osteocyte communication: Impact in a 3D in vitro implant-associated infection model
Giraldo-Osorno, P. M., Wirsig, K., Asa’ad, F., Omar, O., Trobos, M., Bernhardt, A., & Palmquist, A. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.08.005 · Cited by 25
Crystal structures of the components of theStaphylococcus aureusleukotoxin ED
Nocadello, S., Minasov, G., Shuvalova, L., Dubrovska, I., Sabini, E., Bagnoli, F., Grandi, G., & Anderson, W. F. (2015) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798315023207 · Cited by 25
“Indeed, LukE targets CCR5 to kill inflammatory macrophages, dendritic cells and T cells (Alonzo et al., 2013).”
BackgroundSampedro, G. R., & Wardenburg, J. B. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw581 · Cited by 25
Chang, X., Wu, H. L., Webb, G. M., Tiwary, M., Hughes, C. M., Reed, J. S., Hwang, J. M., Waytashek, C. M., Boyle, C. D., Pessoa, C. T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.794638 · Cited by 24
“In addition to HIV, CCR5 is a critical host receptor for Dengue virus (5) and Staphylococcus aureus (6) infection.”
BackgroundGenetic variation of staphylococcal LukAB toxin determines receptor tropism
Perelman, S. S., James, D. B. A., Boguslawski, K. M., Nelson, C. W., Ilmain, J. K., Zwack, E. E., Prescott, R. A., Mohamed, A., Tam, K., Chan, R., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00890-3 · Cited by 24
Self-citationSi, Y., Zhao, F., Beesetty, P., Weiskopf, D., Li, Z., Tian, Q., Alegre, M., Sette, A., Chong, A. S., & Montgomery, C. P. (2020) · Science Advances · doi:10.1126/sciadv.aaw7713 · Cited by 24
Staphylococcus aureus Secreted Toxins and Extracellular Enzymes
Tam, K., & Torres, V. J. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch40 · Cited by 39
Self-citationStaphylococcal α-hemolysin is neurotoxic and causes lysis of brain cells in vivo and in vitro
Dahlberg, D., Mariussen, E., Goverud, I. L., Tønjum, T., Mæhlen, J., Antal, E., & Hassel, B. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.03.001 · Cited by 23
“Staphylococci produce various exotoxins; some target plasma membranes of eukaryotic cells, forming pores and causing cell death, others cause attraction and activation of leukocytes (Menestrina et al., 2003; Genestier et al., 2005; Alonzo et al., 2013; Berube and Bubeck Wardenburg, 2013).”
BackgroundShambat, S. M., Haggar, A., Vandenesch, F., Lina, G., van Wamel, W. J. B., Arakere, G., Svensson, M., & Norrby‐Teglund, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106107 · Cited by 22
Badarau, A., Trstenjak, N., & Nagy, E. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2016_200 · Cited by 20
Response of Cellular Innate Immunity to Cnidarian Pore-Forming Toxins
Yap, W. Y., & Hwang, J. S. (2018) · Molecules · doi:10.3390/molecules23102537 · Cited by 23
Molecular insights into mechanisms of GPCR hijacking by Staphylococcus aureus
Grison, C. M., Lambey, P., Jeannot, S., Nero, E. D., Fontanel, S., Peysson, F., Heuninck, J., Sounier, R., Durroux, T., Leyrat, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108856118 · Cited by 25
“leukotoxin−receptor complexes has only been provided for the LukE−CCR5 pair (16).”
BackgroundLinking S. aureus Immune Evasion Mechanisms to Staphylococcal Vaccine Failures
Hajam, I. A., & Liu, G. Y. (2024) · Antibiotics · doi:10.3390/antibiotics13050410 · Cited by 20
Tam, K., Schultz, M. L., Robles, T. R., Vanwalscappel, B., Horton, J. D., Alonzo, F., Wu, B., Landau, N. R., & Torres, V. J. (2016) · mBio · doi:10.1128/mbio.02024-16 · Cited by 22
“CCR5 is one of four receptors targeted by LukED (5, 24, 25).”
BackgroundMethodInfluentialSelf-citationThe G protein coupled receptor CCR5 in cancer
Upadhyaya, C., Jiao, X., Ashton, A. W., Patel, K., Kossenkov, A. V., & Pestell, R. G. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2019.11.001 · Cited by 21
Han, Y., Xu, S., Huang, K., Xu, X., Hu, F., He, C., Shu, W., Wang, Z., Gong, F., Zhang, C., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00265 · Cited by 24
Laventie, B., Guérin, F., Mourey, L., Tawk, M. Y., Jover, E., Maveyraud, L., & Prévost, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092094 · Cited by 21
Messing with the Sentinels—The Interaction of Staphylococcus aureus with Dendritic Cells
Darisipudi, M. N., Nordengrün, M., Bröker, B. M., & Péton, V. (2018) · Microorganisms · doi:10.3390/microorganisms6030087 · Cited by 26
“LukED targets the C-C chemokine receptor (CCR) 5 as well as the C-X-C motif chemokine receptor (CXCR) 1 and CXCR2, to kill DCs, T cells and Mφs [91,92].”
BackgroundFang, B., Liu, B., & Sun, B. (2020) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2020.151436 · Cited by 20
Preparation and Activities of Macromolecule Conjugates of the CCR5 Antagonist Maraviroc
Asano, S., Gavrilyuk, J. I., Burton, D. R., & Barbas, C. F. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400370w · Cited by 22
Taj, Z., & Chattopadhyay, I. (2024) · Springer eBooks · doi:10.1007/978-981-99-8799-3_8 · Cited by 28
Dendritic cells during Staphylococcus aureus infection: subsets and roles
Wu, X., & Xu, F. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0358-z · Cited by 23
“Through its interaction with CCR5, leukotoxin ED selectively kills CCR5 T lymphocytes and myeloid cells including monocyte-derived DCs in a CCR5-dependent manner [101].”
BackgroundMartin, C., Buckler-White, A. J., Wollenberg, K. R., & Kozak, C. A. (2013) · Journal of Virology · doi:10.1128/jvi.01327-13 · Cited by 21
“The emergence of this CCR5 mutation and its geographic distribution are consistent with a strong selective event, like an epidemic, and although the responsible pathogen has not been identified, CCR5 is the receptor for a toxin produced by Staphylococcus aureus (61).”
BackgroundToda, E., Terashima, Y., Esaki, K., Yoshinaga, S., Sugihara, M., Kofuku, Y., Shimada, I., Suwa, M., Kanegasaki, S., Terasawa, H., et al. (2013) · Biochemical Journal · doi:10.1042/bj20130827 · Cited by 19
Tawk, M. Y., Zimmermann, K., Bossu, J. L., Potrich, C., Bourcier, T., Serra, M. D., Poulain, B., Prévost, G., & Jover, E. (2015) · Cellular Microbiology · doi:10.1111/cmi.12434 · Cited by 20
Foster, T. J., & Geoghegan, J. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00026-5 · Cited by 20
Gene Duplications in the Genomes of Staphylococci and Enterococci
Sánchez-Herrero, J. F., Bernabeu, M., Prieto, A., Hüttener, M., & Juárez, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00160 · Cited by 17
“…infection (Duthie and Lorenz, 1952) and has been commonly used as a model strain both for studying S. aureus pathogenesis (Richardson et al., 2008; Alonzo et al., 2013) and for the assessment of the therapeutic efficacy of antimicrobial compounds designed to threat S. aureus infections…”
BackgroundMethodRuiz-Arroyo, V. M., García‐Robles, I., Ochoa‐Campuzano, C., Goig, G. A., Zaitseva, E., Baaken, G., Martínez‐Ramírez, A. C., Rausell, C., & Real, M. D. (2016) · Insect Molecular Biology · doi:10.1111/imb.12285 · Cited by 20
Role and Function of Regulatory T Cell in Chronic Rhinosinusitis with Nasal Polyposis
Lei, C., Jiang, J., Zhang, Y., & Xiong, G. (2022) · Journal of Immunology Research · doi:10.1155/2022/1144563 · Cited by 18
Strategies for Survival of Staphylococcus aureus in Host Cells
Xu, H., Wang, S., Liu, X., Li, M., Wang, X., Chen, H., Qu, C., Liu, Y., & Liu, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020720 · Cited by 16
Chin, D., Flannagan, R. S., Tuffs, S. W., Chan, J. K., McCormick, J. K., & Heinrichs, D. E. (2022) · Infection and Immunity · doi:10.1128/iai.00099-22 · Cited by 17
Janesch, P., Rouha, H., Weber, S., Malafa, S., Gross, K., Maierhofer, B., Badarau, A., Visram, Z., Stulik, L., & Nagy, E. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.02.004 · Cited by 16
How can Staphylococcus Aureus Phenol-Soluble Modulins be Targeted to Inhibit Infection?
Chatterjee, S. S., & Otto, M. J. (2013) · Future Microbiology · doi:10.2217/fmb.13.37 · Cited by 16
Pathobiont-driven antibody sialylation through IL-10 undermines vaccination
Tsai, C., Hajam, I. A., Caldera, J. R., Chiang, A. W. T., Gonzalez, C., Du, X., Choudhruy, B., Li, H., Suzuki, E., Askarian, F., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179563 · Cited by 18
Host–Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity
Tromp, A. T., van Gent, M., Jansen, J. P., Scheepmaker, L. M., Velthuizen, A., de Haas, C. J. C., van Kessel, K. P. M., Bardoel, B. W., Boettcher, M., McManus, M. T., et al. (2020) · Toxins · doi:10.3390/toxins12020106 · Cited by 16
“LukED targets leukocytes via CC‐chemokine receptor 5 (CCR5), as well as CXC chemokine receptor 1 (CXCR1) and CXC chemokine receptor 2 (CXCR2) [9,10].”
BackgroundLedo, C., Gonzalez, C. D., Garófalo, A. N., Sabbione, F., Keitelman, I. A., Giai, C., Stella, I., Trevani, A. S., & Gómez, M. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.524180 · Cited by 16
“aureus has the particular characteristic of harboring surface molecules that bind to or signal through host molecules other than conventional PRRs, as it is the case of pore forming toxins such as a-toxin that binds ADAM 10 (39), HlgAB that binds CCR2 and CXCR1/2 (40), HlgCB that binds C5aR (40), Luk ED that binds CCR…”
BackgroundIntegrating complex host-pathogen immune environments into S. aureus vaccine studies
Tsai, C., Hajam, I. A., Caldera, J. R., & Liu, G. Y. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.04.003 · Cited by 15
Contribution of staphylococcal virulence factors in the pathogenesis of thrombosis
Lichota, A., Gwoździński, K., Kowalczyk, E., Kowalczyk, M., & Sienkiewicz, M. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127703 · Cited by 13
Zhao, F., Cheng, B. L., Boyle‐Vavra, S., Alegre, M., Daum, R. S., Chong, A. S., & Montgomery, C. P. (2015) · Infection and Immunity · doi:10.1128/iai.00667-15 · Cited by 14
“Hla promotes epithelial damage by binding to ADAM10 (25), Panton-Valentine leukocidin (PVL) binds complement receptors C5a and C5L2 (26), Sbi binds immunoglobulin and interferes with complement activity (27), LukED binds CCR5 on T lymphocytes and CXCR1 and CXCR2 on leukocytes (10, 28), and FnBPA is important in platel…”
BackgroundBoulouis, C., Leeansyah, E., Shambat, S. M., Norrby‐Teglund, A., & Sandberg, J. K. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100912 · Cited by 12
“LukED binds to the chemokine receptor CCR5, expressed on macrophages, dendritic cells, and T cells (38).”
BackgroundStructural insights into recognition of chemokine receptors by Staphylococcus aureus leukotoxins
Lambey, P., Otun, O., Cong, X., Hoh, F., Brunel, L., Verdié, P., Grison, C. M., Peysson, F., Jeannot, S., Durroux, T., et al. (2022) · eLife · doi:10.7554/elife.72555 · Cited by 14
Wang, J., & Holmes, M. C. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.07.007 · Cited by 13
Immune Evasion by Staphylococcus aureus
de Jong, N. W. M., van Kessel, K. P. M., & van Strijp, J. A. G. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch39 · Cited by 13
Microbiome-Independent Effects of Antibiotics in a Murine Model of Nosocomial Infections
Lacey, K. A., González, S. M., Yeung, F., Putzel, G., Podkowik, M. M., Pironti, A., Shopsin, B., Cadwell, K., & Torres, V. J. (2022) · mBio · doi:10.1128/mbio.01240-22 · Cited by 12
Self-citationSause, W. E., Copin, R., O’Malley, A., Chan, R., Morrow, B. J., Buckley, P. T., Fernandez, J., Lynch, A. S., Shopsin, B., & Torres, V. J. (2017) · Journal of Bacteriology · doi:10.1128/jb.00476-17 · Cited by 13
Self-citationde Souza, P. R. K., Ferreira, S. S., Nunes, F. P. B., Casagrande, F. B., Tessaro, F. H. G., Silva, M. C. F., Cruz, J. W. M. C., Mamizuka, E. M., & Martins, J. O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03165 · Cited by 11
de Souza, M. D. S. Q. A., de Souza, C. A., Cunha, L. M. P., de Souza, A. Q. A., de Morais, M. S., & Rabenhorst, S. H. B. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.01.012 · Cited by 11
“These results corroborated the recent in vivo study by Alonzo and Torres (2013) demonstrating that protection against S. aureus was associated with the CCR5D32 allele.”
ResultLegacy of a magic gene— CCR5- ∆ 32 : From discovery to clinical benefit in a generation
O’Brien, S. J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321907121 · Cited by 11
“…recep tor has been demonstrated to serve as the cell surface determinant or mediator for cytotoxic targeting of subsets of myeloid cells and T lymphocytes by the Staphylococcus aureus leukotoxin ED (LukED) (75) Administered maraviroc, the CCR5 antagonist, ablates LukED - mediated cell killing.”
BackgroundShahraki, P. K., Kiani, R., Siavash, M., & Bemani, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-85147-3 · Cited by 10
Metadata
- Authors
- Alonzo III, F., Kozhaya, L., Rawlings, S. A., Reyes-Robles, T., DuMont, A. L., Myszka, D. G., Landau, N. R., Unutmaz, D., & Torres, V. J.
- Affiliations
- New York University (US)
- Corresponding author
- Unutmaz, Derya
- Torres, Victor J.
- ORCID
- Venue
- Nature
- Published
- 2012-12-12
- Volume
- 493
- Issue
- 7430
- Pages
- 51-55
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3536884
- OpenAlex
- W2052831663
- Cited by
- 291
- References
- 43
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 18 · 2023: 17 · 2022: 23 · 2021: 23 · 2020: 26 · 2019: 22 · 2018: 23 · 2017: 19 · 2016: 22 · 2015: 29 · 2014: 23 · 2013: 29
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute of Mental Health (R42MH084372, R42-MH084372-02A1)
- National Institute of Allergy and Infectious Diseases (R21AI087973, R01AI065303, T32AI007180, R56AI091856, F32AI098395)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- CCR5, Staphylococcus aureus, pore-forming toxins, immune evasion, CCR5 antagonist, maraviroc, neutrophils, T cells, myeloid cells, HIV co-receptor, bacterial virulence factors
- MeSH terms
- Animals, Bacterial Toxins, Cells, Cultured, Dendritic Cells, Exotoxins, Female, Humans, Immunologic Memory, Staphylococcus aureus, T-Lymphocytes, Cell Death, Jurkat Cells, Receptors, CCR5, Myeloid Cells, Mice, Immune Evasion, CCR5 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.